Hercules Capital, Inc.

Hercules Capital, Inc.

HCXY

HCXYHercules Capital, Inc. US flag

New York Stock Exchange

24.95

USD

- -

- -

3.52BMarket Cap

CIK

0001280784

ISIN

US4270968476

CUSIP

427096847

Return %

Stock

S&P500

1Y

1.01

26.57

3Y

4.83

76.60

5Y

-7.04

78.48

Use logarithmic scale

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Company Description

CEO: None
Full Time Employees: 100
Sector: Financial Services
Industry: Asset Management
Address: 400 Hamilton Avenue Suite 310Palo Alto, 94301United States San Mateo MD United States of America
IPO Date: Sep 27, 2018
CIK: 0001280784
Website: htgc.com
Similar Companies: BH Macro Limited (BHMU.L)
iPath Bloomberg Lead Subindex Total Return(SM) ETN (LD)
Hennessy Cornerstone Growth Fund Inv Cl (HFCGX)
Small Cap Growth Fund Class A (CGOAX)
Fidelity Advisor Technology Fund Class M (FATEX)
Lyxor MSCI EM Latin America UCITS ETF (LTM.PA)
Business: Hercules Capital, Inc. is a specialty finance company primarily engaged in providing senior secured venture growth loans and other structured debt financing solutions to high-growth, venture capital-backed companies across technology, life sciences, and sustainable and renewable energy industries. Founded in 2003 and headquartered in Palo Alto, California, Hercules operates as a publicly traded business development company (BDC) offering a diverse range of financial products including growth capital financing, convertible, subordinated and mezzanine loans, vendor financing, acquisition financing, pre-IPO and bridge financing, cash flow protection, dividend recapitalizations, and public company financing. The company’s financing supports critical corporate milestones such as product development, market expansion, intellectual property acquisition, and recapitalizations, primarily targeting innovative startups and growth-stage companies in the technology and life sciences sectors. Hercules Capital also operates a wholly owned subsidiary, Hercules Adviser LLC, which manages committed capital and positions the company toward a hybrid asset manager and BDC model. In the past 1-2 years, Hercules Capital has strategically expanded its asset management capabilities through its $1.6 billion subsidiary, enhanced its capital structure by securing a $350 million upsized offering of unsecured notes and an expanded credit facility with MUFG Bank, and maintained conservative leverage ratios to mitigate interest rate and liquidity risks. The company has also focused on increasing its assets under management, which surpassed $5 billion, driven by record debt and equity commitments exceeding $1 billion for consecutive quarters. It has emphasized financing resilient sectors within technology and life sciences while avoiding exposure to more volatile or less strategic markets. Hercules continues to innovate in venture debt financing by supporting new growth capital opportunities, strategic acquisitions, and equity investments in key market-leading companies, maintaining its position as the largest non-bank venture debt lender in the U.S. Hercules Capital targets venture-backed startups and emerging growth companies in industries such as software, biotechnology, healthcare services, drug discovery, and renewable technologies, catering to customers that require non-dilutive capital solutions to extend cash runway and accelerate growth. Its product offerings include senior secured loans, unitranche facilities, convertible debt, and strategic financing solutions tailored for IPO readiness, mergers and acquisitions, and corporate spinouts, serving a global footprint primarily in the U.S. but with financing capabilities for domestic and international expansions. The company has committed over $23 billion to more than 690 portfolio companies since inception, with a strategic focus on sectors expected to be more resilient to market volatility. Overall, Hercules Capital provides comprehensive venture lending and growth capital financing solutions designed for technology and life sciences innovators, supported by strategic expansions in asset management and capital markets activities to sustain competitive advantage and growth in the specialty finance sector. Its conservative financial management and sector-focused investment strategy underpin its stable performance and market leadership within the venture debt domain.

Company News